Research concerns ACD440 – a non-opioid drug which treats peripheral neuropathic pain More: AlzeCure’s neuropathic pain candidate study reaches crucial phase Source: News
read moreSanofi offers retirement scheme to hundreds of staffers at 2 Indian vaccine plants fkansteiner Mon, 01/30/2023 – 13:58 More: Sanofi offers retirement scheme to hundreds of staffers at 2 Indian vaccine plants Source: fierce
read moreAfter trial flop, EU officials take a closer look at Novartis’ Adakveo approval zbecker Mon, 01/30/2023 – 12:29 More: After trial flop, EU officials take a closer look at Novartis' Adakveo approval Source: fierce
read moreMenarini shows Big Pharma how it’s done with first approval for oral SERD drug in breast cancer kdunleavy Mon, 01/30/2023 – 10:22 More: Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer
read moreAmgen, navigating ‘industry headwinds,’ puts 300 commercial jobs on chopping block fkansteiner Mon, 01/30/2023 – 08:34 More: Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block Source: fierce
read moreLilly is calling for Government to freeze the statutory scheme repayment rate for 2023 More: Medicines policy may be halting Government’s drive for growth Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals